Editas Medicine to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Editas Medicine (Nasdaq: EDIT) announced management will participate in two investor conferences in March 2026: TD Cowen 46th Annual Health Care Conference and Barclays 28th Annual Global Healthcare Conference. Both appearances are fireside chats; dates, times, and locations are listed. Live webcasts and archived replays will be available via the company’s Investors website for approximately 30 days after each event.

Investors can view the March 2, 10:30 a.m. ET session in Boston and the March 12, 8:00 a.m. ET session in Miami Beach via the company’s investor webcasts.

News Market Reaction – EDIT

+5.59%

12 alerts

+5.59% News Effect

+2.5% Peak in 1 hr 24 min

+$10M Valuation Impact

$186M Market Cap

0.8x Rel. Volume

On the day this news was published, EDIT gained 5.59%, reflecting a notable positive market reaction. Argus tracked a peak move of +2.5% during that session. Our momentum scanner triggered 12 alerts that day, indicating notable trading interest and price volatility. This price movement added approximately $10M to the company's valuation, bringing the market cap to $186M at that time.

Data tracked by StockTitan Argus on the day of publication.

CAMBRIDGE, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced that management will participate in the following upcoming investor conferences in March:

• TD Cowen 46th Annual Health Care Conference
  Format: Fireside Chat
  Date: Monday, March 2
  Time: 10:30 a.m. ET
  Location: Boston, MA

• Barclays 28th Annual Global Healthcare Conference
  Format: Fireside Chat
  Date: Thursday, March 12
  Time: 8:00 a.m. ET
  Location: Miami Beach, FL

To access the live webcasts of Editas Medicine’s presentations, please visit the “Investors” section of the Company’s website at www.editasmedicine.com. An archived replay will be available for approximately 30 days following each event.

About Editas Medicine 
As a pioneering gene editing company, Editas Medicine is focused on translating the power and potential of the CRISPR genome editing systems into a robust pipeline of transformative in vivo medicines for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and commercialize durable, precision in vivo gene editing medicines for a broad class of diseases. Editas Medicine is the exclusive licensee of Broad Institute’s Cas12a patent estate and Broad Institute and Harvard University’s Cas9 patent estates for human medicines. For the latest information and scientific presentations, please visit www.editasmedicine.com.

Investor and Media Contacts: 
ir@editasmed.com 
media@editasmed.com

FAQ

When will Editas Medicine (EDIT) present at the TD Cowen conference in March 2026?

Editas will present on Monday, March 2, 2026 at 10:30 a.m. ET as a fireside chat. According to the company, the session will be held in Boston at the TD Cowen 46th Annual Health Care Conference and available via webcast on the Investors site.

What are the details for Editas Medicine (EDIT) at the Barclays Global Healthcare Conference in March 2026?

Editas is scheduled for a fireside chat on Thursday, March 12, 2026 at 8:00 a.m. ET in Miami Beach. According to the company, the presentation will be webcast live and an archived replay will be posted on the Investors website for about 30 days.

How can investors watch Editas Medicine (EDIT) livestreams for the March 2026 conferences?

Investors can watch live webcasts via the company’s Investors webpage at www.editasmedicine.com. According to the company, each event will be webcast live and an archived replay will be available for approximately 30 days after the presentation.

Will Editas Medicine (EDIT) provide replay access after the March 2026 conference presentations?

Yes. An archived replay will be available for approximately 30 days following each event. According to the company, replays of the March 2 and March 12 presentations will be posted on the Investors site for investor access.

What format will Editas Medicine's (EDIT) March 2026 appearances take at investor conferences?

Both appearances are scheduled as fireside chats, providing executive discussion rather than a formal presentation. According to the company, management will engage in moderated conversations at TD Cowen on March 2 and Barclays on March 12.